 |
What's New | |
|
Faculty & Staff | |
|
Lin Ji, Ph.D. | |
|
Education | |
|
Specific Diseases | |
|
Videos | |
|
Research | |
|
F.A.Q. | |
|
Glossary of Terms | |
|
Web Links | |
|
Thoracic Center | |
|
Contact Information | |
Dr. Lin Ji was born in Deyong, Sichuan, the People's Republic of China. He received his B.S. in Biochemistry from the University of Sichuan, Chenud, China, his M.S. degree in Biochemistry from The University of Nebraska - Lincolon, and his Ph.D. in Biochemistry from The University of Nebraska - Lincolon. After completing his Ph.D., he accepted a postdoctoral fellowship in the Department of Medicine (Hematology) at the Stanford University School of Medicine. In 1996 Dr. Ji joined M.D. Anderson Cancer Center in the Department of Thoracic and Cardiovascular Surgery as a Research Associate.
Information
Lin Ji , Ph.D.
Research AssociateOffices:
Department of Thoracic and Cardiovascular Surgery
The University of Texas M. D. Anderson Cancer Center
1515 Holcombe Boulevard, Box 109
Houston, TX 77030-4095
Phone: (713) 792-6932
Fax: (713) 794-4901
E-mail:lin_ji
Education:
- The University of Sichuan, Chendu, China, B.S., 1982
- The University of Nebraska - Lincoln, Lincoln, NE, M.S., 1990
- The University of Nebraska - Lincoln, Lincoln, NE, Ph.D., 1993
Society Memberships:
Research Interests:
Dr. Lin Ji's research interests include: development of novel viral and non-viral vector systems for efficiently delivering therapeutical genes in vitro and in vivo for cancer gene therapy; study of functions and mechanisms of tumor suppressor genes such as p53, FHIT and cell regulatory genes such as Bak, Bax in carcinogenesis and in pathways of signal transduction, cell proliferation, apoptosis and cell cycle processes in human cancers; functional characterization of newly isolated putative tumor suppressor genes in human chromosome 3p region; and study of combined effects of anticancer drugs, recombinant adenoviral vectors of tumor suppressor genes, and radiation therapy on growth of human tumors and tumor-derived cell lines in vitro and in vivo. Our goal is to translate these studies into development of diagonostical tools and theraputical agents for human cancers.